Immune Response in Lung Cancer
Conditions
Lung Cancer
Conditions: official terms
Lung Neoplasms
Conditions: Keywords
Immune response, Cancer
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Prospective
Overall Status
Recruiting
Summary
This study is designed to evaluate the importance of the immune cells localization (distribution) between malignant tumor islets and surrounding stroma and to investigate the associations between these immune cells as well as cytokines and clinicopathological and prognostic factors of non-small cell lung cancer (NSCLC) patients.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 80 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

Eastern Cooperative Oncology Group (ECOG) score of 0-1 Patients with histologically documented non-small cell lung cancer Control group - patients without non-small cell lung cancer Written (signed) Informed Consent to participate in the study

Exclusion Criteria:

Any other malignancies within 5 years Any unstable systemic disease (including active infections, significant cardiovascular disease) Prior chemotherapy or radiotherapy Autoimmune disease Nursing or pregnant women
Location
Lithuanian University of Health Sciences
Kaunas, Lithuania
Status: Recruiting
Contact: Remigijus Zaliunas, Professor - +37037327200 - rektoratas@lsmuni.lt
Start Date
March 2013
Completion Date
June 2015
Sponsors
Lithuanian University of Health Sciences
Source
Lithuanian University of Health Sciences
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page